Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (Bone Marrow Transplantation, (2020), 55, 11, (2071-2076), 10.1038/s41409-020-0919-0)

The original HTML and PDF versions of this article were updated shortly after publication to correct author Bregje Verhoeven’s name and affiliation. Bregje Verhoeven was incorrectly associated with Willem-Alexander Children’s Hospital, Department of Pediatrics, Leiden University Medical Center, Leid...

Descripción completa

Detalles Bibliográficos
Autores: Ljungman, Per, Mikulska, Malgorzata, de la Camara, Rafael, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Duarte Palomino, Rafael, Dolstra, Harry, Lankester, Arjan C., Mohty, Mohamad, Montoto, Silvia, Murray, John, de Latour, Régis Peffault, Snowden, John A., Yakoub-Agha, Ibrahim, Verhoeven, Bregje, Kröger, Nicolaus, Styczynski, Jan
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/694701
Acceso en línea:http://hdl.handle.net/10486/694701
https://dx.doi.org/10.1038/s41409-020-0965-7
Access Level:acceso abierto
Palabra clave:SARS-CoV-2
COVID-19
Hematopoietic cell transplantation (HCT)
CAR T cells
European Society for Blood and Marrow Transplantation (EBMT)
Medicina
Descripción
Sumario:The original HTML and PDF versions of this article were updated shortly after publication to correct author Bregje Verhoeven’s name and affiliation. Bregje Verhoeven was incorrectly associated with Willem-Alexander Children’s Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. The correct affiliation is Foundation Hematon, Utrecht, The Netherlands. This has now been corrected in both the PDF and HTML versions of the article.